Skip to content
Home/Companies/Biotech/iOnctura
iOnctura

iOnctura

Biotech·Switzerland·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns iOnctura?

iOnctura is currently owned by XGen Venture SGR through XGEN Venture Life Sciences Fund (2022 vintage), since 2024.

Hand-verified · updated 2026-07-23

XGen Venture SGR
Investor
XGen Venture SGR
XGEN Venture Life Sciences Fund · 2022 · Life Sciences VC

Key facts

HQSwitzerland
SectorBiotech
StatusActive
Websitewww.ionctura.com

More from XGEN Venture Life Sciences Fund

Other portfolio companies in the same fund.

AAVantgarde
AAVantgarde
Active
BiotechItaly· 2025
EpilepsyGTx
Active
BiotechUK· 2025
Gesynta Pharma
Gesynta Pharma
Active
BiotechSweden· 2025
Nanophoria
Active
BiotechItaly· 2025
Genespire
Genespire
Active
BiotechItaly· 2024
Page Therapeutics
Page Therapeutics
Active
BiotechSwitzerland· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track iOnctura

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy iOnctura?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on iOnctura.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue